Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has entered into a non-binding letter of intent (the "LOI") to acquire 100% of Doc Pharma S.A. ("Doc Pharma"), a fully licensed GMP pharmaceutical manufacturer.